Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate stays one of the most important tools in modern-day anaesthesia and intense discomfort management throughout the United Kingdom. As a powerful synthetic opioid, its role in the National Health Service (NHS) and personal surgical sectors is reputable, mostly due to its quick onset of action and cardiovascular stability. This blog post offers a detailed introduction of fentanyl citrate injection solutions available in the UK, their scientific indications, regulatory landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. Fentanyl Citrate Injection Neofax UK was very first manufactured in 1960 and rapidly ended up being a cornerstone of perioperative care. In terms of potency, fentanyl is roughly 50 to 100 times more powerful than morphine. Its high lipophilicity allows it to cross the blood-brain barrier quickly, resulting in an almost instant analgesic effect when administered intravenously.
In the UK, fentanyl citrate is predominantly used via the parenteral path (injection) for both sedative and analgesic purposes. It works mainly by binding to the mu-opioid receptors in the main nerve system, modifying the perception of discomfort and the psychological reaction to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is indicated for several particular scientific scenarios:
- Analgesic Action: Used throughout brief operative procedures and in the healing room.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in mix with a neuroleptic (such as droperidol) to achieve a state of quiescence and reduced awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for clients on mechanical ventilation.
- Pre-medication: To provide sedation and analgesia before the induction of general anaesthesia.
Offered Formulations and Strengths in the UK
The UK market provides several formulas of fentanyl citrate, created to satisfy the differing needs of surgical and emergency departments. These are typically presented as clear, colourless options for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Typical Packaging | Manufacturer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Load of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal usage might sometimes be prepared by medical facility pharmacies under specific procedures.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is vital for safe administration.
- Onset of Action: When administered intravenously, the impact begins nearly immediately, though the optimum analgesic result may take 3 to 5 minutes.
- Period: A single intravenous dose of 100 micrograms normally lasts for 30 to 60 minutes.
- Metabolic process: Fentanyl is mainly metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mostly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and usually performed by anaesthetists or trained specialists in regulated environments.
Dose Guidelines
Dose needs to be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for minor surgical treatments.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more intrusive; needs respiratory tracking.
- High Dose (20-- 50 mcg/kg): Used throughout "worry-free" major surgical treatments (e.g., open-heart surgery) to safeguard the myocardium from the metabolic needs of tension.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less common, but utilized for pre-medication in particular scenarios.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be stored in a locked controlled drug cupboard.
- Record Keeping: Every administration needs to be taped in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl should be denatured and witnessed by authorised personnel.
Side Effects and Adverse Reactions
While extremely effective, fentanyl citrate brings a danger of considerable side impacts.
- Breathing Depression: The most serious adverse effects, which can cause respiratory arrest if not kept an eye on.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, needing using neuromuscular blocking agents.
- Nausea and Vomiting: Common in the postoperative period.
- Hypotension: Although more stable than morphine, it can still occur, particularly in hypovolaemic clients.
Comparison with Other Opioids
Clinicians frequently select fentanyl over other opioids due to its specific pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Beginning | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Duration of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Considerable | Minimal |
| Main Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Often Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl spots?
No. While they contain the very same active drug, the injection is for instant, severe usage in surgical or emergency situation settings. Patches (transdermal shipment) are created for chronic, long-term discomfort management and launch the medication gradually over 72 hours.
2. Can fentanyl citrate be utilized for children in the UK?
Yes, it is frequently used in paediatric anaesthesia. Nevertheless, the dose needs to be strictly calculated based on the kid's weight, and they must be monitored carefully for respiratory depression.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological villain utilized to reverse the results of fentanyl, including respiratory anxiety. In UK medical facilities, naloxone should constantly be readily available anywhere fentanyl is administered.
4. Why is it used over morphine in heart surgery?
Fentanyl is chosen in heart surgery due to the fact that it does not trigger the release of histamine, which can cause vasodilation and hypotension. It supplies cardiovascular stability even at high dosages.
5. What are the storage requirements?
Fentanyl citrate injection must be stored below 25 ° C and safeguarded from light. As a Schedule 2 drug, it must be kept in a lawfully certified CD cupboard.
Fentanyl citrate injection solutions are essential parts of the UK's medical toolkit for managing perioperative discomfort and facilitating intricate surgeries. Its high strength and quick onset deal unrivaled precision for anaesthetists, supplied that extensive monitoring and regulatory standards are kept. By understanding the numerous concentrations and the strict protocols surrounding its usage, healthcare specialists make sure that this effective medication remains both safe and reliable for clients throughout the country.
Disclaimer: This post is for educational purposes only and does not make up medical advice. Healthcare professionals need to constantly describe the Summary of Product Characteristics (SmPC) and current BNF standards for the most up-to-date prescribing information.
